Lifecore Completes Intergel Modular PMA, Anticipates August Panel Review
This article was originally published in The Gray Sheet
Executive Summary
Lifecore Biomedical says it expects FDA to schedule a meeting of the General and Plastic Surgery Devices Panel in August to review the firm's Intergel adhesion prevention solution, following completion of premarket amendment filing March 8.